Adenosine Receptors in Developing and Adult Mouse Neuromuscular Junctions and Functional Links With Other Metabotropic Receptor Pathways

Abstract

In the last few years, we have studied the presence and involvement in synaptogenesis and mature transmitter release of the adenosine autoreceptors (AR) in the mammalian neuromuscular junction (NMJ). Here, we review and bring together the previously published data to emphasize the relevance of these receptors for developmental axonal competition, synaptic loss and mature NMJ functional modulation. However, in addition to AR, activity-dependent mediators originating from any of the three cells that make the synapse (nerve, muscle, and glial cells) cross the extracellular cleft to generate signals in target metabotropic receptors. Thus, the integrated interpretation of the complementary function of all these receptors is needed. We previously studied, in the NMJ, the links of AR with mAChR and the neurotrophin receptor TrkB in the control of synapse elimination and transmitter release. We conclude that AR cooperate with these receptors through synergistic and antagonistic effects in the developmental synapse elimination process. In the adult NMJ, this cooperation is manifested so as that the functional integrity of a given receptor group depends on the other receptors operating normally (i.e., the functional integrity of mAChR depends on AR operating normally). These observations underlie the relevance of AR in the NMJ function.

Introduction

In addition to the main neurotransmitter-receptor signal, several signaling pathways coordinate the pre- and postsynaptic cells and associated glia in the tripartite synapses in accordance with functional demands. In the NMJ, presynaptic mAChRs directly couple ACh secretion to the regulation of the release mechanism itself (Caulfield and Birdsall, 1998; Slutsky et al., 2001; Minic et al., 2002; Santafé et al., 2003, 2004; Garcia et al., 2005). Moreover, presynaptic nicotinic ACh autoreceptors (nAChRs) are also present at the NMJ (Correia-de-Sá, 1994; Salgado et al., 2000). Also, at the NMJ, the presynaptic neurotrophin and cytokine receptors can be influenced by target-derived signals (Bibel and Barde, 2000; Roux and Barker, 2002; Pitts et al., 2006), and glutamate together with mGluR1 also mediate the signaling in this synapse (Waerhaug and Ottersen, 1993; Lück et al., 2000; Malomouzh et al., 2011; Marmiroli and Cavaletti, 2012; Walder et al., 2013).

Studies in the early 1970s Ribeiro and Walker (1973) showed that adenosine and ATP modulate the presynaptic component through purinergic receptors (adenosine P1Rs and ATP P2Rs) (Correia-de-Sá et al., 1991; Ribeiro et al., 1996). The first authors describing adenosine effects at the mammalian NMJ were (Ginsborg and Hirst, 1971, 1972; see also Singh et al., 1986). It is known that both nerve and muscle cell activity can contribute to the extracellular adenosine release (Cunha and Sebastião, 1993; Ribeiro et al., 1996).

In the last few years, we have studied the presence and involvement of AR in the synaptogenesis and transmitter release in the developing and mature mammalian NMJ (Garcia et al., 2013; Tomàs et al., 2014; Tomàs J. et al., 2017; Santafé et al., 2015; Nadal et al., 2016a,b, 2017). Here, we review and bring together previously published data to contribute to emphasizing the relevance of these receptors in this synapse. Moreover, we also discuss our previous studies in relation with the interaction between AR, mAChR and the TrkB in the control of synapse elimination during development and transmitter release in the adult NMJ.

Our results indicate that during NMJ synaptogenesis, AR (A₁R and A_2AR subtypes) contribute to the developmental synapse elimination process, helping to define the winner of the competition between axon terminals. In the adult, AR help to modulate transmitter release by limiting spontaneous quantal leak of ACh and preserve synaptic function by reducing depression during repetitive activity. To realize these functions, several synergistic and antagonistic relations exist between AR and, at least, the mAChR subtypes (M₁, M₂, and M₄) and the TrkB receptor. These observations underlie the relevance of AR in the NMJ function.

Adenosine Receptors Localization in the Nmj

Four subtypes of AR have been cloned (A₁R, A_2AR, A_2BR, and A₃R) and despite the fact that there was some uncertainty about how they were distributed in the cells of the paradigmatic NMJ (Lynge and Hellsten, 2000; Baxter et al., 2005), some of them have been localized in the mouse synapse with confocal immunohistochemistry (Garcia et al., 2005, 2013, 2014; Wright et al., 2009). The confidence of protein localization by immunohistochemistry lies in the specificity of the antibodies used. Though the lack of signal in knockout animals was not investigated, we made an effort to characterize the commercially available antibodies by Western blotting. Our results have shown that the A₁R receptor is more abundant in adult animals, whereas the A_2AR receptor predominates in the newborn ones (Garcia et al., 2013). Moreover, the A_2BR and A₃R receptors are more expressed in the adult muscles than in the younger ones (Tomàs et al., 2014).

Immunofluorescence staining coupled with confocal microscopy analysis was performed to determine the localization of A₁R, A_2AR (whose function has been further investigated) in P6 and P30 NMJ (Figure 1). Moreover, localization of A_2BR, and A₃R has been determined in P30 NMJ. By triple labeling of NMJ we stained each one of these protein receptors in green fluorescence together with Syntaxin or S-100 (blue fluorescence) and nAChR (red fluorescence) and we saw that the molecules were present. However, since the components of the NMJ (the nerve terminal, the Schwann cell and the muscle fiber) are juxtaposed, it is not always easy to locate the proteins with precision. Thus, in some cases, to better determine A₁R and A_2AR localization, we used plastic embedded semithin cross-sections as a tool for high-resolution together with the triple-labeling immunofluorescence analysis. Briefly, after conventional immunohistochemistry the samples were dehydrated with increasing concentrations of ethanol and acetone, the tissue fragments were embedded in Spurr’s resin in transverse orientation and sections (0.5–0.7 μm thick) were obtained (Lanuza et al., 2007; Garcia et al., 2010c; Besalduch et al., 2013). Images (A–D) correspond to a single image made in a confocal microscope from a 0,5 μm muscle semithin cross section. Images (E–F) show localization of A2BR and A3R using single confocal Z planes from a projection image of at least 10 confocal Z planes obtained every 0,5 μm. As shown in Figure 1, these receptors are differentially located in the three cells that configure the NMJs (Garcia et al., 2013, 2014). To the purpose of the present review, it can be noted that the four subtypes of AR are present in the motor endings, which is understood to be a requisite to modulate presynaptic function. However, some AR are localized also in the other synaptic components (for instance A₃R in the postsynaptic site) and the interpretation of the results here is not a full representation of the AR physiology.

FIGURE 1

Garcia et al. (2014) (Garcia N., Priego M., Hurtado E., Obis T., Santafe M. M., Tomàs M., Lanuza M. A., Tomàs J. Adenosine A2B and A3 receptor location at the mouse neuromuscular junction. J. Anat. 225:109–117) and Garcia et al. (2013) (Garcia N., Priego M., Obis T., Santafe M. M., Tomàs M., Besalduch N., Lanuza M. A., Tomàs J. Adenosine A1 and A2A receptor-mediated modulation of acetylcholine release in the mice neuromuscular junction. Eur. J. Neurosci. 38:2229–2241).

Adenosine Receptors Role During Development

During the nervous system development there is an overwhelming production of synapses (that may promote connectiviy), followed by an activity-dependent reduction of them. Hebbian competition between axons refines connectivity and increases specificity (Purves and Lichtman, 1980; Jansen and Fladby, 1990; Sanes and Lichtman, 1999; Chen and Regehr, 2000; Nadal et al., 2016a). In newborn animals, skeletal muscle cells are innervated by various motor axons (Ribchester and Barry, 1994) but when the competition ends, the NMJs retain only one axon (Liu et al., 1994; Nguyen and Lichtman, 1996; Chang and Balice-Gordon, 1997; Sanes and Lichtman, 1999; Herrera and Zeng, 2003; Nelson et al., 2003; Wyatt and Balice-Gordon, 2003; Buffelli et al., 2004).

The postsynaptic cell and the terminal Schwann cells may be intermediary in axonal competition. A decrement in polyneuronal innervation occurs at a time when relatively little loss of the nAChR postsynaptic receptors was observed (Lanuza et al., 2002). However, in some cases, local receptor loss has been observed before the corresponding axon loss (Balice-Gordon and Lichtman, 1993). This suggest that pre- and postsynaptic changes are coordinated. Non-myelinating terminal Schwann cells at the NMJ play a role in synapse elimination (reviewed by Lee et al., 2017). A model has been proposed in which the activity of the Schwann cells promote synapse elimination by creating vacant synaptic sites that can be reoccupied by the competing axon terminals.

At the time this process occurs, several signaling mechanisms coordinate the pre- and postsynaptic cell function. First of all, presynaptic mAChR receptors allow direct competitive interaction between nerve endings because of their different activity-dependent ACh secretion (Santafé et al., 2004, 2007, 2009; Nadal et al., 2016a,b; Tomàs J. et al., 2017). Moreover, we also investigated the involvement of presynaptic AR (A₁R and A_2AR), which monitor both nerve- and muscle-derived adenosine release during the complex period of axonal elimination around P5-P9 (Garcia et al., 2013; Nadal et al., 2016a,b).

We evaluated the average number of axonal connections per NMJ from B6.Cg-Tg (Thy1-YFP) (from now YFP) and C57BL/J6 mice. To the flat and accessible mouse LAL muscle, we subcutaneously applied the unselective AR inhibitor 8-(p-sulfophenyl) theophylline (8SPT) and the agonist adenosine between P5-P15 (Figure 2). At P7, after the inhibition with 8SPT of the AR, we observed an acceleration of the axonal elimination on the NMJ indicating that, at this point of development, the role of AR is to delay axonal loss (Nadal et al., 2016a). In accordance, exposure to the physiological agonist adenosine resulted in a retardation of axonal elimination (i.e., a significant high number of triple innervated NMJ and a reduction in the number of dual innervated NMJ, Figure 2Aa). We also analyzed axonal loss after selectively blocking A₁R with 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) or A_2AR with 2-(2-furanyl)-7-(2-phenylethyl)-7H-pyrazolo[4,3-e] [1, 2, 4] triazolo[1,5-c]pyrimidin-5-amine (SCH-58261) (Nadal et al., 2016a,b). Results showed that axonal loss is accelerated by both inhibitors indicating that, in normal conditions, both receptors A₁R and A_2AR are related with delaying axonal elimination. However, at P9 (Figure 2Ab), the purinergic function accelerates axonal loss to the maximum rate. Therefore, an initial delay in axonal loss at P7 (an A₁R- and A_2AR-mediated effect which can be reinforced by exogenously added adenosine) is followed by an A₁R- and A_2AR-mediated tonic acceleration of axonal loss at P9 (green arrows in Figure 3 left, Nadal et al., 2016a). We also investigated the effect of long-term AR perturbation with 8SPT over axon number at P15. Despite the continued presence of the inhibitor, monoinnervation is achieved in about 90% of NMJ at P15 (Figure 2Ac) suggesting that axonal competition and loss are differentially modulated (Nadal et al., 2016a).

FIGURE 2

Axonal elimination is accompanied by changes in the structure of the nicotinic ACh receptor (nAChR) clusters in the postsynaptic site (Figure 2B). Based on criteria from previous studies on developing mammalian NMJ (Steinbach, 1981; Slater, 1982a,b; Bewick et al., 1996; Lanuza et al., 2002; Garcia et al., 2011), we defined several maturation stages (MS1–MS4). Changes in nAChR distribution transform the uniform nAChR oval cluster at birth (MS1) into an elongated plaque with some heterogeneities in the density of receptors (MS2). Later, they become into clusters with small zones of low receptor density (MS3) that are not innervated that lead to a mature pattern of independent primary gutters (MS4) (Nadal et al., 2016a). In relation with these changes, we found that the antagonist 8SPT, applied in the period P5–P8, had no effect on the clusters morphology when observed at P7 (Figure 2Ba). However, at P9 we found that MS2clusters were increased while the MS1 and MS3 ones decreased (Figure 2Bb), which indicates a delay in the transition from MS2 to MS3. At P15 (Figure 2Bc) the postsynaptic maturation is partially retained at the MS3 stage. Thus, AR are able to accelerate maturation during the P7–P15 period. Interestingly, the agonist adenosine does not unambiguously change the cluster maturation indicating that the tonic effect of the AR evidenced by using 8SPT is close to their maximum (Nadal et al., 2016a).

In summary, AR are involved in the control of the competitive interactions between nerve endings, possibly helping to determine the winner or the losers but, thereafter, axon loss seems to occur with autonomy.

Adenosine Receptors Role in the Adult Neurotransmission

Once a NMJ becomes mature and monoinnervated, AR continue modulating neurotransmission. By measuring the activity-dependent efflux of radiolabelled ACh incorporated in nerve endings, Correia-de-Sá et al. (1991) showed that AR control their nerve-stimulated release. Micromolar adenosine levels reduced evoked and/or spontaneous ACh release in frog NMJs (Searl and Silinsky, 2005; Shakirzyanova et al., 2006; Adámek et al., 2010) and also in rat NMJs (Silinsky et al., 1989; De Lorenzo et al., 2006; Pousinha et al., 2010). However, in rat NMJs, submicromolar adenosine concentrations has the opposite effect (Pousinha et al., 2010). Moreover, in other studies done in mice, only very high doses of adenosine (in the range of millimolar) affected neurotransmission (Silinsky, 2004) and, in concordance, some mammalian endplates were insensitive to adenosine (Ginsborg and Hirst, 1972). Therefore, it remains unclear how and when adenosine and AR modulate neurotransmission. The majority of experiments have been done in electrophysiological recording conditions that interfere with the normal function of the NMJ to prevent muscle contraction. For example, in the ACh efflux experiments hemicholinium-3 prevents choline reuptake, high Mg²⁺ concentrations reduce ACh release and d-tubocurarine reduces postsynaptic response. In these conditions, selective agonists and antagonists of the A₁R and A_2AR modify ACh release. On the one hand, the A₁R agonist 2-Chloro-N⁶-cyclopentyladenosine, 1 μM (CCPA) reduces it (Veggetti et al., 2008) whereas the A_2AR agonist 2-p-(2-Carboxyethyl)- phenethylamino-5′-N-ethylcarboxamidoadenosine hydrochloride hydrate, 1 μM (CGS-21680) increases it (Pousinha et al., 2010). However, A₁R reduces release (in high Mg²⁺ and curare blockade) when the NMJ is already weakened and because of that, the meaning of this regulation seems unclear (Garcia et al., 2013).

Because of these uncertainties, we induced muscle paralysis with μ-CgTx-GIIIB (Garcia et al., 2013; Tomàs et al., 2014; Obis et al., 2015; Santafé et al., 2015; Hurtado et al., 2017a,b), a specific inhibitor of the sodium channel of the muscle cells which preserves NMJ function (Garcia et al., 2013) and its safety factor. This experimental condition mimics the physiological conditions of this synapse in the living animals except for the absence of the contraction-dependent retrograde influence of the muscle cells (Besalduch et al., 2011; Hurtado et al., 2017a,b). We observed that 25 μM adenosine reduced (50%) the quantal content of ACh release in agreement with other authors (Ginsborg and Hirst, 1972; Ribeiro and Walker, 1975). However, in the nearly normal basal conditions (only test stimulations of 70 pulses at 0.5 Hz every 5 min in the presence of μ-CgTx-GIIIB), none of the purinergic agonists or antagonists had any effect on the evoked ACh release. In particular, we tested non-selective AR agonists and antagonists (adenosine and 8SPT, respectively), A₁R-selective agonists and antagonists (CCPA 1 μM and DPCPX 100 nM, respectively) and A_2AR-selective agonists and antagonists (CGS-21680 1 μM and SCH-58261 50 nM, respectively) (Garcia et al., 2013; Tomàs et al., 2014). However, we detected that AR were still functional in reducing the spontaneous release because miniature endplate potentials (MEPP) frequency was increased by SPT8 blockade and decreased by adenosine stimulation, with A₁Rs playing the main role because only DPCPX increased MEPP frequency (Garcia et al., 2013). In addition, imposed synaptic activity (40Hz for 2 min of supramaximal stimuli) resulted in synaptic depression, an effect reduced by micromolar adenosine but potentiated by blocking AR with 8SPT. Depression in control muscles represents a ∼50% reduction of the endplate potentials (EPP) amplitude and 10 μM adenosine reduces it to a half (Garcia et al., 2013). Surprisingly, we found that depression was not affected by any selective agent, which suggested that both A₁R and A_2AR need to collaborate (Garcia et al., 2013; Tomàs et al., 2014). In perspective, the fact that adenosine and 8SPT modified synaptic depression, whereas A₁R and A_2AR ligands did not, suggested us that A_2BR and/or A₃R could be implicated. Thus, we investigated the A_2BR-selective antagonist MRS1706 (N-(4-Acetylphenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]acetamide, 100 nM) and the A₃R-selective antagonist MRS1334 (1,4-Dihydro-2-methyl-6-phenyl-4-(phenylethynyl)-3,5-pyridinedicarboxylic acid 3-ethyl-5-[(3nitrophenyl)methyl] ester, 100 nM). We unexpectedly found that A_2BR and A₃R neither had any effect on depression (just as the A₁R and A_2AR selective antagonists). Thus, we concluded that two or more AR are necessary to protect against depression (Garcia et al., 2013; Tomàs et al., 2014).

In summary, these findings confirmed that in basal conditions AR are not coupled to any immediate modulation of evoked neurotransmission. However, these receptors are still crucial to preserve resources by avoiding the leak of spontaneous quantal ACh, an action which is probably implicated in their protective role against synaptic depression after repetitive activity (Tomàs et al., 2014), (the mature axonal terminal in Figure 3).

FIGURE 3

Links of Ar With Other Metabotropic Receptors (Development and Adulthood)

Activity-dependent mediators derived from the three cells of the synapse cross the extracellular cleft in all directions to generate signals in target metabotropic receptors. In the NMJ, there are other purinergic receptors apart from AR (Tsim and Barnard, 2002; Todd and Robitaille, 2006), several mAChR (Santafé et al., 2007, 2009; Wright et al., 2009; Garcia et al., 2010b), neurotrophin receptors (Gonzalez et al., 1999; Garcia et al., 2011; Santafé et al., 2015; Nadal et al., 2016a,b) cytokine receptors (Ribchester et al., 1998; Wang et al., 2002; Garcia et al., 2010a, 2012), calcitonin gene-related peptide receptors (Changeux et al., 1992; Lu and Fu, 1995; Gaydukov et al., 2016), glutamate receptors (Thomas and Sigrist, 2012; Personius et al., 2016; Tsentsevitsky et al., 2017) and neuregulin receptors (Loeb, 2003; Kummer et al., 2006; Simeone et al., 2010; Schmidt et al., 2011;Wang et al., 2017). The way a synapse operates is largely the outcome of the confluence of several signaling pathways on intracellular kinases, which phosphorylate protein targets and materialize adaptive changes to modulate transmitter release and the stability of the connection. Therefore, the appropriate knowledge of synaptic behavior needs the integrated albeit complex interpretation of the complementary function of these receptors. Thus, we studied the link and interaction of AR with mAChR and the neurotrophin receptor TrkB in the control of synapse elimination during development and transmitter release in the adult NMJ (Nadal et al., 2016a,b, 2017).

In relation with the synapse elimination process during development, in addition to the role of AR subtypes (A₁R and A_2AR) described above, we investigated the involvement of individual mAChR M₁-, M₂-, and M₄-subtypes and the TrkB receptor (Garcia et al., 2010b; Nadal et al., 2016a,b, 2017). Our data indicated that the three receptor sets and all subtypes considered could affect the competition between axon terminals. At P7, for instance, all these receptors taken individually (analyzed through selective inhibition) are involved in favoring initial competition and thus delaying axonal loss. The confluence of the respective downstream pathways can integrate the signals related with the competitive interactions and possibly helps to determine the nerve ending that finally wins and/or the ones that are lost. This competition concludes with the acceleration of the axonal loss 2 days later (around P9; see the eliminated axonal terminal in Figure 3).

To study the collaboration of the AR with mAChR and TrkB, we applied two selective antagonists from two different receptors to see the additive or occlusive effects between them at P9 (Nadal et al., 2016a,b, 2017; Tomàs J. et al., 2017; Tomàs J. M. et al., 2017). These experiments showed the existence of a synergistic role between M₁ and M₄ mAChR, which potentiates the effect of both AR on axonal elimination. Contrarily, the M₂ subtype and the TrkB receptor fully occlude the effects of both A₁R and A_2AR. Interestingly, when both A₁R and A_2AR are blocked at the same time, a mutual occlusion occurs, and the result does not differ from untreated control (Tomàs J. M. et al., 2017).

Thus, both AR are necessary to modulate synapse elimination and several synergistic and antagonistic links are observed between all receptors, which regulate axonal loss (Figure 4A). A₁, M₁, and TrkB are coupled to stimulate PKC whereas A_2A, M₂, and M₄ inhibit PKA. We hypothesize that a membrane receptor-induced shifting in the protein kinases A and C activity in some nerve endings may play an important role in promoting developmental NMJ maturation.

FIGURE 4

In the adult NMJ, it is also known that A₁R and A_2AR as well as the M₁-, M₂-, and M₄-subtypes of mAChR and the TrkB receptor play several roles in the regulation of transmitter release (Minic et al., 2002; Santafé et al., 2003, 2004, 2007, 2009; Garcia et al., 2010b; Tomàs et al., 2011). By using selective agonists and antagonists we observed that, some receptors (i.e., A₁R as previously stated) produce minor changes in spontaneous quantal output (see Figure 3, right) whereas other receptors (i.e., mAChR) induce major changes in evoked release. Thus, each receptor regulates a given combination of spontaneous, evoked and activity-dependent ACh release. As it has been mentioned before, AR preserve resources by reducing spontaneous leak of neurotransmitter (an A₁R effect) and normalize the synapse function because stimulation with adenosine reduces the magnitude of depression during repetitive activity. mAChR stabilize the spontaneous quantal output of ACh and also preserve the synapse function by decreasing evoked release (mainly an M₂ action) and reducing depression. A role for the TrkB receptor is to stabilize the spontaneous quantal leak of ACh but it mainly potentiates evoked release and synaptic potentials (Tomàs et al., 2014).

We also studied the consecutive incubation with two inhibitors affecting two different receptors to see their collaboration in neurotransmission. Adenosine outflow from nerve endings may, through A₁R, reduce M₂ effect on ACh release and adenylyl cyclase may be the shared intracellular node between both pathways (Oliveira et al., 2009). We observed that non-specific AR modulation with 8SPT or adenosine abolishes the effect of a second exposure to the unselective mAChR blocker atropine, but also the effect of the M₁-selective inhibitor pirenzepine and M₂-selective blocker methoctramine. Thus, the normal operation of the AR is necessary for the normal function of the mAChRs (Tomàs et al., 2014) (Figure 4B). However, the same effect is observed in the other way around: a previous blockade of mAChR does not allow applied adenosine to change the above described effect on ACh release in our conditions.

Finally, it has also been reported that adenosine acting through A_2A receptors is able to transactivate the TrkB receptor without the need of neurotrophin binding (Lee and Chao, 2001; Lee et al., 2002; Wiese et al., 2007). Thus, AR are also implicated in the neurotrophic TrkB signaling (Figure 4B).

Concluding Remarks

Autoreceptors subtypes are present in the motor nerve endings in the NMJ. During development, AR modulate the competition between axon terminals, helping to define the winner and the losers (Nadal et al., 2016b). To accomplish this function, AR establish several synergistic and antagonistic relations with, at least, the mAChR subtypes and the TrkB receptor which affect synapse elimination. In the mature NMJ, AR help transmitter release by limiting the spontaneous quantal leak of ACh, which mitigates depression during repetitive activity and preserves synaptic function (Tomàs et al., 2014). In addition, the functional integrity of the AR is crucial for the normal operation of the mAChR and the TrkB pathways. These observations underlie the relevance of AR in the NMJ function.

References

• 1

  AdámekS.ShakirzyanovaA. V.MalomouzhA. I.NaumenkoN. V.VyskočilF. (2010). Interaction of glutamate- and adenosine-induced decrease of acetylcholine quantal release at frog neuromuscular junction.Physiol. Res.59803–810.

  • Pubmed Abstract
  • Google Scholar
  • View reference in article

• 2

  Balice-GordonR.LichtmanJ. (1993). In vivo observations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions. - Semantic Scholar.J. Neurosci.13834–855. 10.1523/JNEUROSCI.13-02-00834.1993

  • CrossRef
  • Google Scholar
  • View reference in article

• 3

  BaxterR. L.Vega-RiverollL. J.DeucharsJ.ParsonS. H. (2005). A_2A adenosine receptors are located on presynaptic motor nerve terminals in the mouse.Synapse57229–234. 10.1002/syn.20173

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 4

  BesalduchN.LanuzaM. A.GarciaN.ObisT.SantafeM. M.TomàsM.et al (2013). Cellular localization of the atypical isoforms of protein kinase C (aPKCζ/PKMζ and aPKCλ/ι) on the neuromuscular synapse.Neurosci. Lett.556166–169. 10.1016/j.neulet.2013.10.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 5

  BesalduchN.SantaféM. M.GarciaN.GonzalezC.TomásM.TomásJ.et al (2011). Transmitter release in the neuromuscular synapse of the protein kinase C theta-deficient adult mouse.J. Comp. Neurol.519849–855. 10.1002/cne.22551

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 6

  BewickG. S.YoungC.SlaterC. R. (1996). Spatial relationships of utrophin, dystrophin, beta-dystroglycan and beta-spectrin to acetylcholine receptor clusters during postnatal maturation of the rat neuromuscular junction.J. Neurocytol.25367–379.

  • Pubmed Abstract
  • Google Scholar
  • View reference in article

• 7

  BibelM.BardeY.-A. (2000). Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system.Genes Dev.142919–2937. 10.1101/gad.841400

  • CrossRef
  • Google Scholar
  • View reference in article

• 8

  BuffelliM.BusettoG.BidoiaC.FaveroM.CangianoA. (2004). Activity-dependent synaptic competition at mammalian neuromuscular junctions.Physiology1985–91. 10.1152/nips.01464.2003

  • CrossRef
  • Google Scholar
  • View reference in article

• 9

  CaulfieldM. P.BirdsallN. J. (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.Pharmacol. Rev.50279–290.

  • Pubmed Abstract
  • Google Scholar
  • View reference in article

• 10

  ChangQ.Balice-GordonR. J. (1997). Nip and tuck at the neuromuscular junction: a role for proteases in developmental synapse elimination.BioEssays19271–275. 10.1002/bies.950190402

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 11

  ChangeuxJ. P.DuclertA.SekineS. (1992). Calcitonin gene-related peptides and neuromuscular interactions.Ann. N. Y. Acad. Sci.657361–378. 10.1111/j.1749-6632.1992.tb22783.x

  • CrossRef
  • Google Scholar
  • View reference in article

• 12

  ChenC.RegehrW. G. (2000). Developmental remodeling of the retinogeniculate synapse.Neuron28955–966. 10.1016/S0896-6273(00)00166-5

  • CrossRef
  • Google Scholar
  • View reference in article

• 13

  Correia-de-SáP.RibeiroJ. A. (1994). Potentiation by tonic A2a-adenosine receptor activation of CGRP-facilitated [3H]-ACh release from rat motor nerve endings.Br. J. Pharmacol.111582–588. 10.1111/j.1476-5381.1994.tb14777.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 14

  Correia-de-SáP.SebastiãoA. M.RibeiroJ. A. (1991). Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat.Br. J. Pharmacol.1031614–1620. 10.1111/j.1476-5381.1991.tb09836.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 15

  CunhaR. A.SebastiãoA. M. (1993). Adenosine and adenine nucleotides are independently released from both the nerve terminals and the muscle fibres upon electrical stimulation of the innervated skeletal muscle of the frog.Pflugers Arch.424503–510. 10.1007/BF00374914

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 16

  De LorenzoS.VeggettiM.MuchnikS.LosavioA. (2006). Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction.Neuroscience14271–85. 10.1016/j.neuroscience.2006.05.062

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 17

  GarciaN.PriegoM.HurtadoE.ObisT.SantafeM. M.TomàsM.et al (2014). Adenosine A2B and A3 receptor location at the mouse neuromuscular junction.J. Anat.225109–117. 10.1111/joa.12188

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 18

  GarciaN.PriegoM.ObisT.SantafeM. M.TomàsM.BesalduchN.et al (2013). Adenosine A1 and A2A receptor-mediated modulation of acetylcholine release in the mice neuromuscular junction.Eur. J. Neurosci.382229–2241. 10.1111/ejn.12220

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 19

  GarciaN.SantaféM. M.SalonI.LanuzaM. A.TomàsJ. (2005). Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat.Histol. Histopathol.20733–743. 10.14670/HH-20.733

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 20

  GarciaN.SantaféM. M.TomàsM.LanuzaM. A.BesalduchN.PriegoM.et al (2010a). The glial cell line-derived neurotrophic factor (GDNF) does not acutely change acetylcholine release in developing and adult neuromuscular junction.Neurosci. Lett.480127–131. 10.1016/j.neulet.2010.06.022

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 21

  GarciaN.SantaféM. M.TomàsM.PriegoM.ObisT.LanuzaM. A.et al (2012). Exogenous ciliary neurotrophic factor (CNTF) reduces synaptic depression during repetitive stimulation.J. Peripher. Nerv. Syst.17312–323. 10.1111/j.1529-8027.2012.00419.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 22

  GarciaN.TomàsM.SantaféM. M.BesalduchN.LanuzaM. A.TomàsJ. (2010b). The interaction between tropomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals.J. Neurosci.3016514–16522. 10.1523/JNEUROSCI.2676-10.2010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 23

  GarciaN.TomàsM.SantafeM. M.LanuzaM. A.BesalduchN.TomàsJ. (2010c). Localization of brain-derived neurotrophic factor, neurotrophin-4, tropomyosin-related kinase b receptor, and p75NTR receptor by high-resolution immunohistochemistry on the adult mouse neuromuscular junction.J. Peripher. Nerv. Syst.1540–49. 10.1111/j.1529-8027.2010.00250.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 24

  GarciaN.TomàsM.SantafeM. M.LanuzaM. A.BesalduchN.TomàsJ. (2011). Blocking p75NTR receptors alters polyinnervation of neuromuscular synapses during development.J. Neurosci. Res.891331–1341. 10.1002/jnr.22620

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 25

  GaydukovA. E.BogachevaP. O.BalezinaO. P. (2016). Calcitonin gene-related peptide increases acetylcholine quantal size in neuromuscular junctions of mice.Neurosci. Lett.62817–23. 10.1016/j.neulet.2016.06.014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 26

  GinsborgB. L.HirstG. (1971). Cyclic AMP, transmitter release and the effect of adenosine on neuromuscular transmission.Nat. New Biol.23263–64. 10.1038/newbio232063a0

  • CrossRef
  • Google Scholar
  • View reference in article

• 27

  GinsborgB. L.HirstG. D. (1972). The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat.J. Physiol.224629–645. 10.1113/jphysiol.1972.sp009916

  • CrossRef
  • Google Scholar
  • View reference in article

• 28

  GonzalezM.RuggieroF. P.ChangQ.ShiY. J.RichM. M.KranerS.et al (1999). Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions.Neuron24567–583. 10.1016/S0896-6273(00)81113-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 29

  HerreraA. A.ZengY. (2003). Activity-dependent switch from synapse formation to synapse elimination during development of neuromuscular junctions.J. Neurocytol.32817–833. 10.1023/B:NEUR.0000020626.29900.fb

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 30

  HurtadoE.CillerosV.JustL.SimóA.NadalL.TomàsM.et al (2017a). Synaptic activity and muscle contraction increases PDK1 and PKCβI phosphorylation in the presynaptic membrane of the neuromuscular junction.Front. Mol. Neurosci.10:270. 10.3389/fnmol.2017.00270

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 31

  HurtadoE.CillerosV.NadalL.SimóA.ObisT.GarciaN.et al (2017b). Muscle contraction regulates BDNF/TrkB signaling to modulate synaptic function through presynaptic cPKCα and cPKCβI.Front. Mol. Neurosci.10:147. 10.3389/fnmol.2017.00147

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 32

  JansenJ. K.FladbyT. (1990). The perinatal reorganization of the innervation of skeletal muscle in mammals.Prog. Neurobiol.3439–90. 10.1016/0301-0082(90)90025-C

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 33

  KummerT. T.MisgeldT.SanesJ. R. (2006). Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost.Curr. Opin. Neurobiol.1674–82. 10.1016/j.conb.2005.12.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 34

  LanuzaM. A.BesalduchN.GarciaN.SabatéM.SantaféM. M.TomàsJ. (2007). Plastic-embedded semithin cross-sections as a tool for high-resolution immunofluorescence analysis of the neuromuscular junction molecules: specific cellular location of protease-activated receptor-1.J. Neurosci. Res.85748–756. 10.1002/jnr.21192

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 35

  LanuzaM. A.GarciaN.SantaféM.GonzálezC. M.AlonsoI.NelsonP. G.et al (2002). Pre- and postsynaptic maturation of the neuromuscular junction during neonatal synapse elimination depends on protein kinase C.J. Neurosci. Res.67607–617. 10.1002/jnr.10122

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 36

  LeeF. S.ChaoM. V. (2001). Activation of Trk neurotrophin receptors in the absence of neurotrophins.Proc. Natl. Acad. Sci. U.S.A.983555–3560. 10.1073/pnas.061020198

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 37

  LeeF. S.RajagopalR.KimA. H.ChangP. C.ChaoM. V. (2002). Activation of trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides.J. Biol. Chem.2779096–9102. 10.1074/jbc.M107421200

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 38

  LeeY. I.ThompsonW. J.HarlowM. L. (2017). Schwann cells participate in synapse elimination at the developing neuromuscular junction.Curr. Opin. Neurobiol.47176–181. 10.1016/j.conb.2017.10.010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 39

  LiuY.FieldsR. D.FestoffB. W.NelsonP. G. (1994). Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction.Proc. Natl. Acad. Sci. U.S.A.9110300–10304. 10.1073/pnas.91.22.10300

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 40

  LoebJ. A. (2003). Neuregulin: an activity-dependent synaptic modulator at the neuromuscular junction.J. Neurocytol.32649–664. 10.1023/B:NEUR.0000020640.84708.35

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 41

  LuB.FuW.-M. (1995). Regulation of postsynaptic responses by calcitonin gene related peptide and ATP at developing neuromuscular junctions.Can. J. Physiol. Pharmacol.731050–1056. 10.1139/y95-149

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 42

  LückG.HochW.HopfC.BlottnerD. (2000). Nitric oxide synthase (NOS-1) coclustered with agrin-induced AChR-specializations on cultured skeletal myotubes.Mol. Cell. Neurosci.16269–281. 10.1006/mcne.2000.0873

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 43

  LyngeJ.HellstenY. (2000). Distribution of adenosine A₁, A_2A and A_2B receptors in human skeletal muscle.Acta Physiol. Scand.169283–290. 10.1046/j.1365-201x.2000.00742.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 44

  MalomouzhA. I.NikolskyE. E.VyskočilF. (2011). Purine P2Y receptors in ATP-mediated regulation of non-quantal acetylcholine release from motor nerve endings of rat diaphragm.Neurosci. Res.71219–225. 10.1016/j.neures.2011.07.1829

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 45

  MarmiroliP.CavalettiG. (2012). The glutamatergic neurotransmission in the central nervous system.Curr. Med. Chem.191269–1276. 10.2174/092986712799462711

  • CrossRef
  • Google Scholar
  • View reference in article

• 46

  MinicJ.MolgóJ.KarlssonE.KrejciE. (2002). Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase.Eur. J. Neurosci.15439–448. 10.1046/j.0953-816x.2001.01875.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 47

  NadalL.GarciaN.HurtadoE.SimóA.TomàsM.LanuzaM. A.et al (2016a). Synergistic action of presynaptic muscarinic acetylcholine receptors and adenosine receptors in developmental axonal competition at the neuromuscular junction.Dev. Neurosci.38407–419. 10.1159/000458437

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 48

  NadalL.GarciaN.HurtadoE.SimóA.TomàsM.LanuzaM. A.et al (2016b). Presynaptic muscarinic acetylcholine autoreceptors (M1, M2 and M4 subtypes), adenosine receptors (A1 and A2A) and tropomyosin-related kinase B receptor (TrkB) modulate the developmental synapse elimination process at the neuromuscular junction.Mol. Brain91–19. 10.1186/s13041-016-0248-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 49

  NadalL.GarciaN.HurtadoE.SimóA.TomàsM.LanuzaM. A.et al (2017). Presynaptic muscarinic acetylcholine receptors and TrkB receptor cooperate in the elimination of redundant motor nerve terminals during development).Front. Aging Neurosci.9:24. 10.3389/fnagi.2017.00024

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 50

  NelsonP. G.LanuzaM. A.JiaM.LiM.-X.TomasJ. (2003). Phosphorylation reactions in activity-dependent synapse modification at the neuromuscular junction during development.J. Neurocytol.32803–816. 10.1023/B:NEUR.0000020625.70284.a6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 51

  NguyenQ. T.LichtmanJ. W. (1996). Mechanism of synapse disassembly at the developing neuromuscular junction.Curr. Opin. Neurobiol.6104–112. 10.1016/S0959-4388(96)80015-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 52

  ObisT.BesalduchN.HurtadoE.NadalL.SantafeM. M.GarciaN.et al (2015). The novel protein kinase C epsilon isoform at the adult neuromuscular synapse: location, regulation by synaptic activity-dependent muscle contraction through TrkB signaling and coupling to ACh release.Mol. Brain81–16. 10.1186/s13041-015-0098-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 53

  OliveiraL.TimóteoM. A.Correia-de-SáP. (2009). Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate.Neurosci. Lett.459127–131. 10.1016/j.neulet.2009.05.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 54

  PersoniusK. E.SlusherB. S.UdinS. B. (2016). Neuromuscular NMDA receptors modulate developmental synapse elimination.J. Neurosci.368783–8789. 10.1523/JNEUROSCI.1181-16.2016

  • CrossRef
  • Google Scholar
  • View reference in article

• 55

  PittsE. V.PotluriS.HessD. M.Balice-GordonR. J. (2006). Neurotrophin and Trk-mediated signaling in the neuromuscular system.Int. Anesthesiol. Clin.4421–76. 10.1097/00004311-200604420-00004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 56

  PousinhaP. A.CorreiaA. M.SebastiaoA. M.RibeiroJ. A. (2010). Predominance of adenosine excitatory over inhibitory effects on transmission at the neuromuscular junction of infant rats.J. Pharmacol. Exp. Ther.332153–163. 10.1124/jpet.109.157255

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 57

  PurvesD.LichtmanJ. W. (1980). Elimination of synapses in the developing nervous system.Science210153–157. 10.1126/science.7414326

  • CrossRef
  • Google Scholar
  • View reference in article

• 58

  RibchesterR. R.BarryJ. A. (1994). Spatial versus consumptive competition at polyneuronally innervated neuromuscular junctions.Exp. Physiol.79465–494. 10.1113/expphysiol.1994.sp003781

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 59

  RibchesterR. R.ThomsonD.HaddowL. J.UshkaryovY. A. (1998). Enhancement of spontaneous transmitter release at neonatal mouse neuromuscular junctions by the glial cell line-derived neurotrophic factor (GDNF).J. Physiol.512635–641. 10.1111/j.1469-7793.1998.635bd.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 60

  RibeiroJ. A.CunhaR. A.Correia-de-SáP.SebastiãoA. M. (1996). Purinergic regulation of acetylcholine release.Prog. Brain Res.109231–241. 10.1016/S0079-6123(08)62107-X

  • CrossRef
  • Google Scholar
  • View reference in article

• 61

  RibeiroJ. A.WalkerJ. (1973). Action of adenosine triphosphate on endplate potentials recorded from muscle fibres of the rat-diaphragm and frog sartorius.Br. J. Pharmacol.49724–725. 10.1111/j.1476-5381.1973.tb08555.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 62

  RibeiroJ. A.WalkerJ. (1975). The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions.Br. J. Pharmacol.54213–218. 10.1111/j.1476-5381.1975.tb06931.x

  • CrossRef
  • Google Scholar
  • View reference in article

• 63

  RouxP. P.BarkerP. A. (2002). Neurotrophin signaling through the p75 neurotrophin receptor.Prog. Neurobiol.67203–233. 10.1016/S0301-0082(02)00016-3

  • CrossRef
  • Google Scholar
  • View reference in article

• 64

  SalgadoA. I.CunhaR. A.RibeiroJ. (2000). Facilitation by P2 receptor activation of acetylcholine release from rat motor nerve terminals: interaction with presynaptic nicotinic receptors.Brain Res.877245–250. 10.1016/S0006-8993(00)02679-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 65

  SanesJ. R.LichtmanJ. W. (1999). Developement of the vertebrate neuromuscular junction.Annu. Rev. Neurosci.22389–442. 10.1146/annurev.neuro.22.1.389

  • CrossRef
  • Google Scholar
  • View reference in article

• 66

  SantaféM. M.GarciaN.LanuzaM. A.TomàsM.TomàsJ. (2009). Interaction between protein kinase C and protein kinase A can modulate transmitter release at the rat neuromuscular synapse.J. Neurosci. Res.87683–690. 10.1002/jnr.21885

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 67

  SantaféM. M.LanuzaM. A.GarciaN.TomàsM.TomàsJ. (2007). Coupling of presynaptic muscarinic autoreceptors to serine kinases in low and high release conditions on the rat motor nerve terminal.Neuroscience148432–440. 10.1016/j.neuroscience.2007.06.017

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 68

  SantaféM. M.PriegoM.ObisT.GarciaN.TomàsM.LanuzaM. A.et al (2015). Adenosine receptors and muscarinic receptors cooperate in acetylcholine release modulation in the neuromuscular synapse.Eur. J. Neurosci.421775–1787. 10.1111/ejn.12922

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 69

  SantaféM. M.SalonI.GarciaN.LanuzaM. A.UchitelO. D.TomàsJ. (2003). Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat.Eur. J. Neurosci.17119–127. 10.1046/j.1460-9568.2003.02428.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 70

  SantaféM. M.SalonI.GarciaN.LanuzaM. A.UchitelO. D.TomàsJ. (2004). Muscarinic autoreceptors related with calcium channels in the strong and weak inputs at polyinnervated developing rat neuromuscular junctions.Neuroscience12361–73. 10.1016/j.neuroscience.2003.09.012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 71

  SchmidtN.AkaabouneM.GajendranN.Martinez-PenaY.ValenzuelaI.WakefieldS.et al (2011). Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin.J. Cell Biol.1951171–1184. 10.1083/jcb.201107083

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 72

  SearlT. J.SilinskyE. M. (2005). Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog.Br. J. Pharmacol.145954–962. 10.1038/sj.bjp.0706248

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 73

  ShakirzyanovaA. V.BukharaevaE. A.NikolskyE. E.GiniatullinR. A. (2006). Negative cross-talk between presynaptic adenosine and acetylcholine receptors.Eur. J. Neurosci.24105–115. 10.1111/j.1460-9568.2006.04884.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 74

  SilinskyE. M. (2004). Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.J. Physiol.558389–401. 10.1113/jphysiol.2004.061457

  • CrossRef
  • Google Scholar
  • View reference in article

• 75

  SilinskyE. M.SolsonaC.HirshJ. K. (1989). Pertussis toxin prevents the inhibitory effect of adenosine and unmasks adenosine-induced excitation of mammalian motor nerve endings.Br. J. Pharmacol.9716–18. 10.1111/j.1476-5381.1989.tb11918.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 76

  SimeoneL.StraubingerM.KhanM. A.NallewegN.CheusovaT.HashemolhosseiniS. (2010). Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction.J. Neurosci.306620–6634. 10.1523/JNEUROSCI.5778-09.2010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 77

  SinghY. N.DrydenW. F.ChenH. (1986). The inhibitory effects of some adenosine analogues on transmitter release at the mammalian neuromuscular junction.Can. J. Physiol. Pharmacol.641446–1450. 10.1139/y86-245

  • CrossRef
  • Google Scholar
  • View reference in article

• 78

  SlaterC. R. (1982a). Neural influence on the postnatal changes in acetylcholine receptor distribution at nerve-muscle junctions in the mouse.Dev. Biol.9423–30. 10.1016/0012-1606(82)90064-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 79

  SlaterC. R. (1982b). Postnatal maturation of nerve-muscle junctions in hindlimb muscles of the mouse.Dev. Biol.9411–22. 10.1016/0012-1606(82)90063-X

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 80

  SlutskyI.SilmanI.ParnasI.ParnasH. (2001). Presynaptic M2 muscarinic receptors are involved in controlling the kinetics of ACh release at the frog neuromuscular junction.J. Physiol.536717–725. 10.1111/j.1469-7793.2001.00717.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 81

  SteinbachJ. H. (1981). Developmental changes in acetylcholine receptor aggregates at rat skeletal neuromuscular junctions.Dev. Biol.84267–276. 10.1016/0012-1606(81)90394-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 82

  ThomasU.SigristS. J. (2012). Glutamate receptors in synaptic assembly and plasticity: case studies on fly NMJs.Adv. Exp. Med. Biol.9703–28. 10.1007/978-3-7091-0932-8_1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 83

  ToddK. J.RobitailleR. (2006). Purinergic modulation of synaptic signalling at the neuromuscular junction.Pflügers Arch.452608–614. 10.1007/s00424-006-0068-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 84

  TomàsJ.GarciaN.LanuzaM. A.SantaféM. M.TomàsM.NadalL.et al (2017). Presynaptic membrane receptors modulate ACh release, axonal competition and synapse elimination during neuromuscular junction development.Front. Mol. Neurosci.10:132. 10.3389/fnmol.2017.00132

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 85

  TomàsJ. M.GarciaN.LanuzaM. A.NadalL.TomàsM.HurtadoE.et al (2017). Membrane receptor-induced changes of the protein kinases A and C activity may play a leading role in promoting developmental synapse elimination at the neuromuscular junction.Front. Mol. Neurosci.10:255. 10.3389/fnmol.2017.00255

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 86

  TomàsJ.SantaféM. M.GarciaN.LanuzaM. A.TomàsM.BesalduchN.et al (2014). Presynaptic membrane receptors in acetylcholine release modulation in the neuromuscular synapse.J. Neurosci. Res.92543–554. 10.1002/jnr.23346

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 87

  TomàsJ.SantaféM. M.LanuzaM. A.GarcíaN.BesalduchN.TomàsM. (2011). Silent synapses in neuromuscular junction development.J. Neurosci. Res.893–12. 10.1002/jnr.22494

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 88

  TsentsevitskyA.NurullinL.NikolskyE.MalomouzhA. (2017). Metabotropic and ionotropic glutamate receptors mediate the modulation of acetylcholine release at the frog neuromuscular junction.J. Neurosci. Res.951391–1401. 10.1002/jnr.23977

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 89

  TsimK. W. K.BarnardE. A. (2002). The signaling pathways mediated by P2Y nucleotide receptors in the formation and maintenance of the skeletal neuromuscular junction.Neurosignals1158–64. 10.1159/000057322

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 90

  VeggettiM.MuchnikS.LosavioA. (2008). Effect of purines on calcium-independent acetylcholine release at the mouse neuromuscular junction.Neuroscience1541324–1336. 10.1016/j.neuroscience.2008.04.056

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 91

  WaerhaugO.OttersenO. P. (1993). Demonstration of glutamate-like immunoreactivity at rat neuromuscular junctions by quantitative electron microscopic immunocytochemistry.Anat. Embryol.188501–513. 10.1007/bf00190144

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 92

  WalderK. K.RyanS. B.BzdegaT.OlszewskiR. T.NealeJ. H.LindgrenC. A. (2013). Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction.Eur. J. Neurosci.37118–129. 10.1111/ejn.12027

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 93

  WangC.-Y.YangF.HeX.-P.JeH.-S.ZhouJ.-Z.EckermannK.et al (2002). Regulation of neuromuscular synapse development by glial cell line-derived neurotrophic factor and neurturin.J. Biol. Chem.27710614–10625. 10.1074/jbc.M106116200

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 94

  WangJ.SongF.LoebJ. A. (2017). Neuregulin1 fine-tunes pre-, post-, and perisynaptic neuromuscular junction development.Dev. Dyn.246368–380. 10.1002/dvdy.24494

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 95

  WieseS.JablonkaS.HoltmannB.OrelN.RajagopalR.ChaoM. V.et al (2007). Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB.Proc. Natl. Acad. Sci. U.S.A.10417210–17215. 10.1073/pnas.0705267104

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 96

  WrightM. C.PotluriS.WangX.DentchevaE.GautamD.TesslerA.et al (2009). Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.J. Neurosci.2914942–14955. 10.1523/JNEUROSCI.2276-09.2009

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 97

  WyattR. M.Balice-GordonR. J. (2003). Activity-dependent elimination of neuromuscular synapses.J. Neurocytol.32777–794. 10.1023/B:NEUR.0000020623.62043.33

  • CrossRef
  • Google Scholar
  • View reference in article